ATE496933T1 - Reines rocuroniumbromid - Google Patents

Reines rocuroniumbromid

Info

Publication number
ATE496933T1
ATE496933T1 AT06803587T AT06803587T ATE496933T1 AT E496933 T1 ATE496933 T1 AT E496933T1 AT 06803587 T AT06803587 T AT 06803587T AT 06803587 T AT06803587 T AT 06803587T AT E496933 T1 ATE496933 T1 AT E496933T1
Authority
AT
Austria
Prior art keywords
rocuronium bromide
bromide
pure rocuronium
pure
pyrrolidinim
Prior art date
Application number
AT06803587T
Other languages
English (en)
Inventor
Juana Mendez
La Mora Marco De
Alejandro Guillen
Hugo Herrera
Original Assignee
Sicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37757118&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE496933(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sicor Inc filed Critical Sicor Inc
Application granted granted Critical
Publication of ATE496933T1 publication Critical patent/ATE496933T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Gyroscopes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT06803587T 2005-09-13 2006-09-13 Reines rocuroniumbromid ATE496933T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US71712205P 2005-09-13 2005-09-13
US75267105P 2005-12-19 2005-12-19
US75243505P 2005-12-20 2005-12-20
US77632206P 2006-02-23 2006-02-23
US78474606P 2006-03-21 2006-03-21
PCT/US2006/035828 WO2007073424A1 (en) 2005-09-13 2006-09-13 Pure rocuronium bromide

Publications (1)

Publication Number Publication Date
ATE496933T1 true ATE496933T1 (de) 2011-02-15

Family

ID=37757118

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06803587T ATE496933T1 (de) 2005-09-13 2006-09-13 Reines rocuroniumbromid

Country Status (13)

Country Link
US (4) US7569687B2 (de)
EP (4) EP1924592A2 (de)
JP (2) JP2008522983A (de)
KR (3) KR20070085703A (de)
CN (1) CN101687905A (de)
AT (1) ATE496933T1 (de)
BR (1) BRPI0605937A2 (de)
CA (2) CA2617816A1 (de)
DE (2) DE602006019822D1 (de)
ES (1) ES2288811T5 (de)
MX (1) MX2008000933A (de)
TW (2) TW200804410A (de)
WO (2) WO2007033348A2 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1687308B1 (de) * 2003-11-17 2019-06-12 Merck & Cie Verfahren zur Herstellung von (6R)-L-Erythrotetrahydrobiopterin Hydrochlorid kristalliner Form B aus anderen kristallinen Formen
WO2005118586A1 (en) * 2004-06-02 2005-12-15 Sandoz Ag Meropenem intermediate in crystalline form
CN101687905A (zh) * 2005-09-13 2010-03-31 西科尔公司 纯罗库溴铵
BRPI0616040A2 (pt) * 2005-09-21 2011-06-07 Nycomed Gmbh cloridrato de sulfonilpirról como inibidor de histona desacetilases
EP2404911A1 (de) * 2005-10-31 2012-01-11 Janssen Pharmaceutica NV Neue Verfahren zur Herstellung von Piperazinyl- und Diazapanylbenzamidderivate
CA2656057C (en) * 2006-06-16 2012-10-02 H. Lundbeck A/S Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
CA2667345C (en) * 2006-10-27 2016-03-22 Signal Pharmaceuticals, Llc Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
GB2445746A (en) * 2007-01-17 2008-07-23 Texcontor Ets Use of carbonated water as a solvent for freeze drying, and method of purification comprising dissolution of material in carbonated water and freeze drying
WO2009016648A2 (en) * 2007-07-30 2009-02-05 Gland Pharma Limited Process for the preparation of rocuronium bromide and intermediate thereof
EP2085397A1 (de) * 2008-01-21 2009-08-05 Esteve Quimica, S.A. Kristalline Form von Abacavir
US7935817B2 (en) * 2008-03-31 2011-05-03 Apotex Pharmachem Inc. Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof
AR071318A1 (es) * 2008-04-15 2010-06-09 Basilea Pharmaceutica Ag Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso
US8097719B2 (en) * 2008-07-15 2012-01-17 Genesen Labs Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem
KR101016608B1 (ko) * 2008-12-03 2011-02-22 (주) 성운파마코피아 로큐로니움 브로마이드의 제조방법
CN101863948B (zh) * 2009-04-17 2013-07-24 重庆医药工业研究院有限责任公司 高纯度(2β,3α,5α,16β,17β)-2-(4-吗啉基)-16-(1-吡咯烷基)-雄甾烷-3,17-二醇或其组合物及其制备方法
KR101713453B1 (ko) 2010-03-12 2017-03-07 오메로스 코포레이션 Pde10 억제제 및 관련 조성물 및 방법
CN101824066B (zh) * 2010-04-08 2012-06-13 浙江仙琚制药股份有限公司 制备罗库溴铵中间体化合物结晶物的方法
JP2013536859A (ja) * 2010-09-01 2013-09-26 アリーナ ファーマシューティカルズ， インコーポレイテッド ５−ｈｔ２ｃアゴニストの非吸湿性塩
CN103119051B (zh) * 2011-01-26 2015-09-23 浙江华海药业股份有限公司 罗库溴铵的制备方法
EP2703408B1 (de) * 2011-04-25 2015-08-26 Zhejiang Huahai Pharmaceutical Co., Ltd. Verfahren zur reinigung von rocuroniumbromid
EP2760859A1 (de) * 2011-09-30 2014-08-06 Sunshine Lake Pharma Co., Ltd Kristalline formen von azilsartan, ihre herstellung und verwendung
CN102633858A (zh) * 2012-03-06 2012-08-15 连云港贵科药业有限公司 罗库溴铵关键中间体2α,3α-环氧-16β-(1-吡咯烷基)-5α-雄甾烷-17羟基的制备方法
CN103588847A (zh) * 2012-08-17 2014-02-19 重庆医药工业研究院有限责任公司 一种罗库溴铵中间体的制备方法
JP6382816B2 (ja) * 2013-07-24 2018-08-29 田辺三菱製薬株式会社 眼科疾患治療剤
CN103435674B (zh) * 2013-09-09 2015-05-06 山东新华制药股份有限公司 高纯度、高稳定性罗库溴铵的制备方法
CN103435675B (zh) * 2013-09-25 2015-05-13 宜昌人福药业有限责任公司 一种甾类肌松药的精制方法
NZ630803A (en) 2014-04-28 2016-03-31 Omeros Corp Optically active pde10 inhibitor
NZ716494A (en) 2014-04-28 2017-07-28 Omeros Corp Processes and intermediates for the preparation of a pde10 inhibitor
JP2016121073A (ja) * 2014-12-24 2016-07-07 ニプロ株式会社 注射剤用医薬組成物の製造方法
KR20170139074A (ko) 2015-04-24 2017-12-18 오메로스 코포레이션 Pde10 억제제 및 관련 조성물 및 방법
WO2017079678A1 (en) 2015-11-04 2017-05-11 Omeros Corporation Solid state forms of a pde10 inhibitor
CN106950314A (zh) * 2017-04-17 2017-07-14 南京健友生化制药股份有限公司 一种检测罗库溴铵或其注射液中烯丙基溴含量的方法
CN107312055A (zh) * 2017-06-08 2017-11-03 江苏正大清江制药有限公司 一种罗库溴铵新的制备方法
IL326637A (en) * 2017-09-07 2026-04-01 Atnx Spv Llc Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide
CN108676052B (zh) * 2018-08-16 2020-05-22 北京市新里程医药科技有限公司 一种罗库溴铵的制备方法及其药物组合物
CN109053855B (zh) * 2018-10-08 2020-02-14 台州仙琚药业有限公司 一种16β-四氢吡咯基雄甾-2α-环氧-17-酮的合成方法
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
CN111196835B (zh) * 2019-12-27 2021-10-26 成都新恒创药业有限公司 一种罗库溴铵晶型
CN111303230B (zh) * 2020-03-09 2021-07-13 中国食品药品检定研究院 一种黄体酮共晶物及其制备方法和用途
CN114088842B (zh) * 2021-11-19 2023-03-21 江苏正济药业股份有限公司 一种罗库溴铵中间体及杂质的检测方法
CN115925776A (zh) * 2022-12-15 2023-04-07 浙江共同共新医药科技有限公司 一种制备罗库溴铵中间体的方法
CN116925171B (zh) * 2023-07-10 2025-06-27 时森海(杭州)医药科技有限公司 含环丙甲基甾体类季铵盐化合物、中间体及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138605A (en) * 1965-02-19 1969-01-01 Organon Labor Ltd Improvements in or relating to new 2-ß,16-ß-diamino-androstanes
IE53463B1 (en) * 1981-06-15 1988-11-23 Akzo Nv Mono-and bisquaternary ammonium derivatives of 2 beta,16 beta-d-amino-5 alpha-androstane derivatives and pharmaceutical preparations containing same
GB8708886D0 (en) * 1987-04-14 1987-05-20 Akzo Nv 2beta-morpholino-androstane derivatives
GB8709565D0 (en) 1987-04-23 1987-05-28 Akzo Nv 2beta,16beta-diaminoandrostanes
HU210076B (en) * 1992-11-02 1995-01-30 Tuba Process for producing androstane derivatives substituted with quaternisaeted amino group in 16-position and for producing pharmaceutical compositions containing them
IT1277700B1 (it) 1995-12-22 1997-11-11 Poli Ind Chimica Spa Processo di preparazione di 2-beta, 16-beta-diamino 3-alfa, 17-beta- diacilossi 5-alfaandrostani, bloccanti neuromuscolari a struttura
JP3440741B2 (ja) * 1997-03-04 2003-08-25 戸田工業株式会社 磁気カード用マグネトプランバイト型フェライト粒子粉末
DE19903894A1 (de) 1999-02-01 2000-08-03 Scheiber Gerd Arzneimittelkombination zur Muskelrelaxation in Anaestesie und Intensivmedizin
WO2005068487A2 (en) 2004-01-15 2005-07-28 Chemagis Ltd. Processes for the preparation of rocuronium bromide and intermediates thereof
US20060058275A1 (en) 2004-07-15 2006-03-16 Oded Friedman Processes for preparing stabilized, highly pure rocuronium bromide
US20060058276A1 (en) * 2004-07-15 2006-03-16 Oded Friedman Processes for the preparation and purification of rocuronium bromide
US20060009485A1 (en) 2005-06-23 2006-01-12 Chemagis Ltd Method of reprocessing quaternary ammonium-containing neuromuscular blocking agents
CN101687905A (zh) 2005-09-13 2010-03-31 西科尔公司 纯罗库溴铵
KR20070075390A (ko) 2007-06-25 2007-07-18 진철 금나노입자를 이용한 근이완제 Rocuronium의 효능개선 및작열감해소

Also Published As

Publication number Publication date
EP2119723A1 (de) 2009-11-18
EP1828221A1 (de) 2007-09-05
ES2288811T1 (es) 2008-02-01
DE06803587T1 (de) 2007-11-22
US7569687B2 (en) 2009-08-04
US20070117975A1 (en) 2007-05-24
TW200804409A (en) 2008-01-16
EP1828221B2 (de) 2013-12-25
US20090093632A1 (en) 2009-04-09
WO2007033348A2 (en) 2007-03-22
CA2617816A1 (en) 2007-03-22
TW200804410A (en) 2008-01-16
EP1924592A2 (de) 2008-05-28
JP2008519865A (ja) 2008-06-12
KR20070085703A (ko) 2007-08-27
WO2007073424A8 (en) 2008-02-07
KR20080025763A (ko) 2008-03-21
ES2288811T5 (es) 2014-02-24
DE602006019822D1 (de) 2011-03-10
KR20100095013A (ko) 2010-08-27
JP2008522983A (ja) 2008-07-03
US7642246B2 (en) 2010-01-05
WO2007033348A3 (en) 2008-02-28
EP2107066A2 (de) 2009-10-07
ES2288811T3 (es) 2011-04-20
MX2008000933A (es) 2008-03-26
EP2107066A3 (de) 2009-10-21
US20070265237A1 (en) 2007-11-15
CN101687905A (zh) 2010-03-31
EP1828221B1 (de) 2011-01-26
CA2618272A1 (en) 2007-06-28
US20090137794A1 (en) 2009-05-28
WO2007073424A1 (en) 2007-06-28
BRPI0605937A2 (pt) 2009-05-26

Similar Documents

Publication Publication Date Title
ATE496933T1 (de) Reines rocuroniumbromid
NL301113I1 (nl) Tucatinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout of solvaat
DE602006004251D1 (de) Instrument für Endoscope und Instrumentsystem für Endoscope.
DK1847611T3 (da) Rhamnose-inducerbart ekspressionssystem
ATE548374T1 (de) 2&#39;-fluor-2&#39;-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
NO20064454L (no) Matstang og fremgangsmåte for fremstilling derav.
DK1560812T3 (da) Aminocyclohexyletherforbindelser og anvendelser deraf
DE602004023251D1 (de) Phantom für Qualitätskontrolle
ITMO20050009A1 (it) Apparato di serraggio.
NL1032793A1 (nl) Spectroscopiesysteem.
TW200727920A (en) New regimens for oral monophasic contraceptives
EP1911299A4 (de) Servicequalität-updateverfahren
EA200702529A1 (ru) Фунгицидная комбинация биологически активных веществ
ITRM20050304A1 (it) Supporto per pannello strumenti.
NO20064762L (no) Heisdorsystem
IL185653A0 (en) Pharmaceutical compositions containing an antibody which binds the stalk region of kim-1
ITPR20030089A1 (it) Valvola di omogeneizzazione.
NO20040947L (no) Laseanordning for kumlokk.
ITTO20030817A1 (it) Copertura perfezionata per altoparlanti, particolarmente per autovetture.
ITMO20050084A1 (it) &#39;manufatto cermico per pareti ventilate o simili.&#39;
ITVI20030199A1 (it) Apparecchio per la climatizzazione di locali.
ITPR20040013A1 (it) Apparato di ozonizzazione.
ITTV20050095A1 (it) Supporto per manico di violino.
ITCR20050006U1 (it) Supporto per strumenti ad arco.
DE202005000976U1 (de) Stütze für die Füße

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties